To evaluate the clinical utility of the CAMUNI-MATISS 20-year risk score, recently validated for the Italian population, as additional screening tool for individuals at "low" (ESC-SCORE Project predicted 10-year risk ≤ 1%; no preventive action), "intermediate" (ESC-SCORE 1-4%; lifestyle modification/statin treatment) and "high" risk (ESC-SCORE≥ 4% or diabetes; statin treatment) according to the Italian regulation.
OS 06-07 COMBINING SHORT- AND LONG-TERM RISK SCORES IN PRIMARY PREVENTION OF MAJOR CARDIOVASCULAR DISEASE EVENTS IN LOW INCIDENCE POPULATIONS: AN ASSESSMENT OF CLINICAL UTILITY
VERONESI, GIOVANNI;GIANFAGNA, FRANCESCO;FERRARIO, MARCO MARIO ANGELO
2016-01-01
Abstract
To evaluate the clinical utility of the CAMUNI-MATISS 20-year risk score, recently validated for the Italian population, as additional screening tool for individuals at "low" (ESC-SCORE Project predicted 10-year risk ≤ 1%; no preventive action), "intermediate" (ESC-SCORE 1-4%; lifestyle modification/statin treatment) and "high" risk (ESC-SCORE≥ 4% or diabetes; statin treatment) according to the Italian regulation.
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
